Occult retinopathy following treatment of Hepatitis C with glecaprevir/pibrentasvir (Mavyret)

ConclusionsGiven the temporal relationship between Mavyret administration and vision loss in our patient, and the absence of an underlying cause after extensive evaluation, we propose that Mavyret may be associated with a toxic occult retinopathy characterized by panretinal dysfunction without clinically apparent structural findings.

Source: Documenta Ophthalmologica - February 10, 2023 Category: Opthalmology Source Type: research